Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 11, 2008, Pages 3268-3273

  Chu, Lisa W ^a   Zhu, Yong ^b   Yu, Kai ^a   Zheng, Tongzhang ^b   Chokkalingam, Anand P ^c   Stanczyk, Frank Z ^d   Gao, Yu Tang ^e   Hsing, Ann W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e SHANGHAI CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANEDIOL; ANDROSTANOLONE; GLOBULIN; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

AGED; ARTICLE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HORMONE BINDING; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

AGED; ALLELES; ANALYSIS OF VARIANCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CASEIN KINASE IEPSILON; CELL CYCLE PROTEINS; CHINA; CIRCADIAN RHYTHM; FLAVOPROTEINS; GENETIC MARKERS; GENETIC VARIATION; GENOTYPE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; TRANSCRIPTION FACTORS;

EID: 55849128160     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0073     Document Type: Article

References (35)

1. Panda S, Hogenesch JB. It's all in the timing: many clocks, many outputs. J Biol Rhythms 2004;19:374-87.
2. Lejeune-Lenain C, Van Cauter E, Desir D, Beyloos M, Franckson JR. Control of circadian and episodic variations of adrenal androgens secretion in man. J Endocrinol Invest 1987;10:267-76.
3. Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl 1989;10:366-71.
4. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-61.
5. Chu LW, Zhu Y, Yu K, et al. Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis 2007 [epub ahead of print].
6. Luboshitzky R, Zabari Z, Shen-Orr Z, Herer P, Lavie P. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2001;86:1134-9.
7. Luboshitzky R, Aviv A, Hefetz A, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab 2002;87:3394-8.
8. Miller BH, Olson SL, Turek FW, et al. Circadian clock mutation disrupts estrous cyclicity and maintenance of pregnancy. Curr Biol 2004;14:1367-73.
9. Meinhardt UJ, Ho KKY. Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 2006;65:413-22.
10. Archer SN, Robilliard DL, Skene DJ, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003;26:413-5.
11. Carpen JD, Archer SN, Skene DJ, Smits M, von Schantz M. A single-nucleotide polymorphism in the 5′-untranslated region of the hPER2 gene is associated with diurnal preference. J Sleep Res 2005;14:293-7.
12. Carpen JD, von Schantz M, Smits M, Skene DJ, Archer SN. A silent polymorphism in the PER1 gene associates with extreme diurnal preference in humans. J Hum Genet 2006;51:1122-5.
13. Hsing AW, Stanczyk FZ, Belanger A, et al. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 2007;16:1004-8.
14. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72.
15. Chokkalingam AP, Pollak M, Fillmore CM, et al. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 2001;10:421-7.
16. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein 3: genetic factors. Cancer Epidemiol Biomarkers Prev 2005;14:1394-401.
17. Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 2005;14:268-70.
18. 394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer 2007;120:432-5.
19. Riva A, Kohane IS. SNPper: retrieval and analysis of human SNPs. Bioinformatics 2002;18:1681-5.
20. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-7.
21. Niu Y, Xu Y, Zhang J, et al. Proliferation and differentiation of prostatic stromal cells. BJU Int 2001;87:386-93.
22. Hsing AW, Reichardt JK, Stanczyk FZ. Hormones and prostate cancer: current perspectives and future directions. Prostate 2002;52:213-35.
23. Chokkalingam AP, Stanczyk FZ, Reichardt JKV, Hsing AW. Molecular epidemiology of prostate cancer: hormone-related genetic loci. Front Biosci 2007;12:3436-60.
24. Stratakis CA, Mastorakos G, Magiakou MA, et al. 24-Hour secretion of growth hormone (GH), insulin-like growth factors-I and-II (IGF1,-II), prolactin (PRL) and thyrotropin (TSH) in young adults of normal and tall stature. Endocr Res 1996;22:261-76.
25. Goodman-Gruen DD, Barrett-Connor EE. Epidemiology of insulin-like growth factor 1 in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-6.
26. Oscarsson JJ, Johannsson GG, Johansson JJO, et al. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults. Clin Endocrinol (Oxf) 1997;46:63-8.
27. Heuck CC, Skjaerbaek CC, Orskov HH, Wolthers OOD. Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children. Pediatr Res 1999;45:733-6.
28. Skjaerbaek CC, Frystyk JJ, Kaal AA, et al. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGFII in untreated and treated acromegaly and growth hormone deficiency. Clin Endocrinol (Oxf) 2000;52:25-33.
29. Haus EE, Dumitriu LL, Nicolau GGY, Bologa SS, Sackett-Lundeen LL. Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP3), cortisol, and melatonin in women with breast cancer. Chronobiol Int 2001;18:709-27.
30. Sjogren K, Leung K-C, Kaplan W, et al. Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men. Am J Physiol Endocrinol Metab 2007;293:E364-71.
31. Zhu Y, Stevens R, Leaderer D, et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 2008;107:421-5.
32. Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein 3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
33. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
34. Guay A, Miller MG, McWhirter CL. Does early morning versus late morning draw time influence apparent testosterone concentration in men aged ≥45 years? Data from the Hypogonadism In Males study. Int J Impot Res 2007;20:162-7.
35. Crawford ED, Barqawi AB, O'Donnell C, Morgentaler A. The association of time of day and serum testosterone concentration in a large screening population. BJU Int 2007;100:509-13.